Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What can we expect from prophylactic implantable defibrillators?

D J Wilber1, J G Kall, D E Kopp

  • 1Section of Cardiology, University of Chicago Hospitals, Illinois 60637, USA.

The American Journal of Cardiology
|September 18, 1997
PubMed
Summary

Sudden cardiac death from ventricular tachyarrhythmia (VT) is a major concern, especially for post-myocardial infarction (MI) patients. Implantable defibrillators show promise for high-risk survivors, but optimal patient selection is still evolving.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of radiofrequency current on previously implanted pacemaker and defibrillator ventricular lead systems.

Journal of electrocardiology·2002
Same author

Successful external cardioversion of atrial fibrillation in patients referred to an electrophysiologist for internal cardioversion.

Clinical cardiology·2001
Same author

A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification.

Journal of the American College of Cardiology·2000
Same author

Atypical atrial flutter originating in the right atrial free wall.

Circulation·2000
Same author

Frozen shoulder syndrome associated with subpectoral defibrillator implantation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·1999
Same author

Retrograde fast pathway ablation for atrioventricular nodal reentry associated with markedly prolonged PR intervals.

The American journal of cardiology·1999

Area of Science:

  • Cardiology
  • Electrophysiology
  • Public Health

Background:

  • Ventricular tachyarrhythmia (VT) causes significant mortality, particularly in patients with a history of myocardial infarction (MI).
  • Standard therapies (aspirin, beta-blockers, ACE inhibitors) form the baseline for comparison with new interventions.
  • Previous trials of antiarrhythmic drugs like amiodarone and sotalol have shown limited survival benefits.

Purpose of the Study:

  • To evaluate the role of prophylactic interventions in reducing mortality in post-MI survivors.
  • To assess the effectiveness of implantable defibrillators in specific high-risk subgroups.
  • To understand the evolving criteria for selecting patients for defibrillator therapy.

Main Methods:

  • Review of existing therapeutic benchmarks and randomized trials.

Related Experiment Videos

  • Analysis of data from the Multicenter Automatic Defibrillator Implantation Trial (MADIT).
  • Focus on identifying high-risk post-MI populations for prophylactic interventions.

    • Main Results:

    • Implantable defibrillators significantly improved survival in a select group of post-MI patients with high short-term mortality risk (MADIT trial).
    • Empiric amiodarone and class III antiarrhythmic drug trials (d,l-sotalol, d-sotalol) did not consistently demonstrate survival benefits.
    • Targeting higher-risk subgroups involves trade-offs in overall mortality impact.

    Conclusions:

    • Implantable defibrillators are a viable option for specific high-risk post-MI survivors.
    • Ongoing research and trials are crucial for refining patient selection criteria for defibrillator therapy.
    • The optimal use of prophylactic interventions for VT in post-MI patients requires continued investigation.